<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04626310</url>
  </required_header>
  <id_info>
    <org_study_id>1710 1R21MH119530-01A1</org_study_id>
    <secondary_id>R21MH119530-01A1</secondary_id>
    <nct_id>NCT04626310</nct_id>
  </id_info>
  <brief_title>Mapping Aspects of Psychotherapy in Dialectical Behavior Therapy</brief_title>
  <acronym>MAP-DBT</acronym>
  <official_title>Mapping Treatment Components to Targets in Dialectical Behavior Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Amherst</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Toledo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Massachusetts, Amherst</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although dialectical behavior therapy (DBT) skills training is effective in the treatment of&#xD;
      borderline personality disorder, it contains four skills modules and there is little research&#xD;
      to guide their modular application. This study compares the unique effects of two distinct&#xD;
      DBT skills training modules, relative to a non-DBT therapy group for adults with borderline&#xD;
      personality disorder. Using innovative laboratory-based assessment methods, the proposed&#xD;
      study will examine the effects of these conditions on emotional responding and interpersonal&#xD;
      functioning, as well as clinical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Borderline personality disorder (BPD) is a severe mental health condition with high morbidity&#xD;
      and mortality. Although dialectical behavior therapy (DBT) is an efficacious treatment for&#xD;
      BPD, it is resource-intensive and lengthy in its full form, involving one year of weekly&#xD;
      individual therapy and group skills training in mindfulness, emotion regulation,&#xD;
      interpersonal effectiveness, and distress tolerance. As a result, few patients have access to&#xD;
      the full treatment. A better understanding of how the distinct components of DBT affect&#xD;
      different sets of symptoms could help to streamline this treatment and personalize its use&#xD;
      with specific patients.&#xD;
&#xD;
      Improvements in both interpersonal and emotional functioning are theorized to underlie&#xD;
      improvements in BPD. Thus, emotion regulation and interpersonal effectiveness skills training&#xD;
      may be particularly important components of DBT. Therefore, this study examines the unique&#xD;
      effects of two distinct DBT skills training modules.&#xD;
&#xD;
      Participants are adults with BPD and recent, recurrent self-injurious behaviors (planned N =&#xD;
      81) who are randomly assigned to six weeks of DBT emotion regulation skills training&#xD;
      (DBT-ER), DBT interpersonal effectiveness skills training (DBT-IE), or a non-skills control&#xD;
      group. Using innovative laboratory-based multimethod assessments, this study examines the&#xD;
      effects of these conditions on emotional responding and interpersonal functioning, as well as&#xD;
      BPD related outcomes. Aim 1 examines the unique effects of DBT-ER and DBT-IE on their&#xD;
      respective emotion-related (subjective and biological emotional reactivity, behavioral&#xD;
      emotion regulation, skills use) and interpersonal (subjective and behavioral) targets,&#xD;
      compared to the non-DBT treatment. Aim 2 examines whether improved emotional functioning&#xD;
      predicts reductions in BPD symptoms and self-injury. Aim 3 examines whether baseline emotion&#xD;
      dysregulation interacts with treatment condition to predict treatment response.&#xD;
&#xD;
      The proposed research is innovative in its experimental examination of the effects of DBT&#xD;
      components on specific targets in BPD. Given the high societal costs of BPD, this work has&#xD;
      important public health significance. Findings will inform larger studies evaluating the&#xD;
      potential modular use of DBT components to result in briefer and more efficient&#xD;
      individualized treatments for patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in emotional functioning</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7, follow-up week 13-14</time_frame>
    <description>Assessed with the Difficulties in Emotion Regulation Scale (DERS), which has total scores that range from 36-180, with higher scores indicating more difficulties</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in borderline personality disorder features</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7, follow-up week 13-14</time_frame>
    <description>Assessed with the abbreviated Borderline Symptom List (BSL23), which has mean scores that range from 0-4, with higher scores indicating more symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported emotional reactivity</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7, follow-up week 13-14</time_frame>
    <description>Assessed with self-reported emotions in response to emotional cues presented in the lab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported emotional regulation</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7</time_frame>
    <description>Assessed with self-reported emotions in response to regulation instructions for emotional cues presented in the lab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in affect-modulated startle</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7</time_frame>
    <description>Assessed with eyeblink startle amplitude in response to emotional cues presented in the lab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in emotional habituation</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7</time_frame>
    <description>Assessed with skin conductance (microsiemens) in response to repeated emotional cues presented in the lab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physiological emotional reactivity</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7</time_frame>
    <description>Assessed with skin conductance (microsiemens) in response to emotional cues presented in the lab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in deliberate physiological emotional regulation</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7</time_frame>
    <description>Assessed with heart rate variability (ms2/hz) in response to emotional cues presented in the lab</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in coping strategies</measure>
    <time_frame>Pre-treatment, mid-treatment week 3-4, post-treatment week 6-7, follow-up week 13-14</time_frame>
    <description>Assessed with the DBT-Ways of Coping Checklist (DBT-WCCL), which yields scales of skills use, general dysfunctional coping, and blaming others, with mean scores of 0-3, with higher levels indicating greater use of those strategies</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Borderline Personality Disorder</condition>
  <arm_group>
    <arm_group_label>Dialectical behavior therapy - emotion regulation skills training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dialectical behavior therapy - emotion regulation skills training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dialectical behavior therapy - interpersonal effectiveness skills training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dialectical behavior therapy - interpersonal effectiveness skills training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-skills-oriented interpersonal psychotherapy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-skills-oriented interpersonal psychotherapy group</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dialectical behavior therapy - emotion regulation skills training</intervention_name>
    <description>Arm 1. Dialectical behavior therapy - emotion regulation skills training follows the emotion regulation skills DBT Skills Training Manual Second Edition and the DBT Skills Training Handouts and Worksheets Second Edition. This group involves 6 weekly sessions.&#xD;
Arm 2. Dialectical behavior therapy - interpersonal effectiveness skills training follows the interpersonal effectiveness skills DBT Skills Training Manual Second Edition and the DBT Skills Training Handouts and Worksheets Second Edition. This group involves 6 weekly sessions.</description>
    <arm_group_label>Dialectical behavior therapy - emotion regulation skills training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dialectical behavior therapy - interpersonal effectiveness skills training</intervention_name>
    <description>Arm 2. Dialectical behavior therapy - interpersonal effectiveness skills training follows the interpersonal effectiveness skills DBT Skills Training Manual Second Edition and the DBT Skills Training Handouts and Worksheets Second Edition. This group involves 6 weekly sessions.</description>
    <arm_group_label>Dialectical behavior therapy - interpersonal effectiveness skills training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interpersonal psychotherapy</intervention_name>
    <description>Arm 3. Non-skills-oriented interpersonal psychotherapy group follows evidence-based principles on common factors in a group therapy context. This group involves 6 weekly sessions.</description>
    <arm_group_label>Non-skills-oriented interpersonal psychotherapy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. exhibit 4+ BPD symptoms,&#xD;
&#xD;
          2. have a history of recent (i.e., past-year) and recurrent (&gt; 1 instance) of&#xD;
             self-injury,&#xD;
&#xD;
          3. commit to participate in one of our 6-week experimental groups,&#xD;
&#xD;
          4. have an individual health provider who can manage imminent issues,&#xD;
&#xD;
          5. be between 18-60 years old,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. not fluent in English,&#xD;
&#xD;
          2. have impaired (uncorrected) vision or hearing that would impair ability to understand&#xD;
             study stimuli,&#xD;
&#xD;
          3. a current manic, psychotic, or active physiological dependence on substances (to limit&#xD;
             interference in the lab),&#xD;
&#xD;
          4. low cognitive functioning (IQ â‰¤ 70.4 (TOPF; Pearson Assessments, 2009),&#xD;
&#xD;
          5. past DBT treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine L Dixon-Gordon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Massachusetts, Amherst</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katherine L Dixon-Gordon, PhD</last_name>
    <phone>413-354-0053</phone>
    <email>katiedg@umass.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychological Services Center, University of Massachusetts Amherst</name>
      <address>
        <city>Amherst</city>
        <state>Massachusetts</state>
        <zip>01002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine L Dixon-Gordon, PhD</last_name>
      <phone>413-545-0226</phone>
      <email>caslab@psych.umass.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 1, 2020</study_first_submitted>
  <study_first_submitted_qc>November 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Amherst</investigator_affiliation>
    <investigator_full_name>Katherine Dixon-Gordon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Dialectical behavior therapy</keyword>
  <keyword>Emotions</keyword>
  <keyword>Behavior and Behavior mechanisms</keyword>
  <keyword>Randomized Controlled Trials</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Specific data archive decisions are pending.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

